Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

Adare Pharmaceuticals, Inc., a clinical-stage pharmaceutical company and leading global provider of advanced pharmaceutical technologies, development and manufacturing, today announced that it has acquired the pharmaceutical technology company, Orbis Biosciences, Inc. of Lenexa, KS. The acquisition of Orbis will enhance Adare’s Pharmaceutical Technologies business, which develops and manufactures products for global pharmaceutical, animal health and over-the-counter (OTC) markets. The acquisition was finalized on April 30th for an undisclosed amount. Orbis Biosciences will maintain its operations in Lenexa, KS and integration of the companies will commence immediately.

Read the full article: Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences //


Scroll to Top